Can-Fite BioPharma Ltd.
(NYSE Amex Equities : CANF)

( )
CANF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.26%203.421.3%$752.26m
GILDGilead Sciences, Inc.
0.14%64.220.9%$374.75m
CELGCelgene Corporation
0.03%95.711.3%$325.97m
ALXNAlexion Pharmaceuticals, Inc.
7.53%123.492.0%$306.94m
ILMNIllumina, Inc.
-0.66%288.583.5%$277.12m
BIIBBiogen Inc.
-0.48%232.061.3%$268.05m
VRTXVertex Pharmaceuticals Incorporated
-1.16%184.241.9%$256.63m
EXASExact Sciences Corporation
-1.14%117.8724.1%$239.89m
REGNRegeneron Pharmaceuticals, Inc.
-0.93%295.022.6%$203.40m
AAgilent Technologies, Inc.
-0.69%71.701.6%$193.78m
SRPTSarepta Therapeutics, Inc.
-6.34%95.0714.7%$184.59m
BMRNBioMarin Pharmaceutical Inc.
-1.05%77.404.3%$97.47m
INCYIncyte Corporation
-0.59%85.562.5%$96.06m
GHDXGenomic Health, Inc.
-1.12%73.521.8%$85.99m
SGENSeattle Genetics, Inc.
-2.01%78.366.5%$79.57m

Company Profile

Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer. Can-Fite BioPharma was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach Tikva, Israel.